Nine for 2023, part three: thriving or surviving?
pharmaphorum
JANUARY 24, 2023
In 2023, pharmaceutical companies must unlearn the old lessons of commercial engagement, where frequency and face-to-face were key, and focus on the quality of meaningful interaction, where a healthcare professional’s attention is fully engaged and the experience is meaningful to their work. Medicines manufacturing is energy intensive.
Let's personalize your content